ZANTE GREG (Chief Financial Officer) sold 23.3% of their position (57.66K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.90M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+41K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
+32.05K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−31.96K
Price / share
$32.30
Trade value
$1.03M
% of position
Common Stock, par value $0.00001 per share
Shares
−13.90K
Price / share
$33.38
Trade value
$464.02K
% of position
Common Stock, par value $0.00001 per share
Shares
−10.30K
Price / share
$34.24
Trade value
$352.63K
% of position
Common Stock, par value $0.00001 per share
Shares
−1.50K
Price / share
$32.09
Trade value
$48.13K
% of position
Net shares
+15.39K
Net value
-$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +41K | — | — | 23.5% | 174.48K | 215.48K |
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +32.05K | — | — | 14.9% | 215.48K | 247.53K |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −31.96K | $32.30 | $1.03M | 12.9% | 247.53K | 215.57K |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −13.90K | $33.38 | $464.02K | 6.4% | 215.57K | 201.67K |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −10.30K | $34.24 | $352.63K | 5.1% | 201.67K | 191.37K |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −1.50K | $32.09 | $48.13K | 0.8% | 191.39K | 189.89K |
| Total | +15.39K | -$1.90M | ||||||
Stock Option (Right to Buy)
Common Stock
91K shares
Shares
+91K
Strike price
35.42
Held after
91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock91K shares | 1/2/2026 | A · Award | +91K | 35.42 | — | 91K |